Skip to main content

Peer Review reports

From: Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report

Original Submission
26 Jun 2023 Submitted Original manuscript
7 Jul 2023 Reviewed Reviewer Report - Ali Fanoodi
26 Jul 2023 Reviewed Reviewer Report - Shanila Ahmed
27 Jul 2023 Reviewed Reviewer Report - Mirette Hanna
15 Aug 2023 Author responded Author comments - Auro del Giglio
Resubmission - Version 2
15 Aug 2023 Submitted Manuscript version 2
22 Aug 2023 Editorially accepted
25 Sep 2023 Article published 10.1186/s13256-023-04139-x

You can find further information about peer review here.

Back to article page